Eikonizo Therapeutics
Janice Kranz is the CEO & Co-Founder at Eikonizo Therapeutics. Janice has 25 years of experience in startups: Cubist, Proteome (Incyte). Previously, she was a Grant Writer, Project Manager, Research Informatics at Collaborative Drug Discovery - CDD VAULT.
Janice earned her Ph.D. in Biology from Harvard University in 1993.
Eikonizo Therapeutics
Eikonizo is developing life-changing therapies by creating brain-penetrant small molecules and deploying in vivo target engagement techniques to accelerate the identification of therapeutics. Their first program is focused on a disease-modifying therapeutics for neurodegenerative diseases.